Integer Holdings (ITGR) AI Stock Analysis

• Market Cap: $4.21B
• Dividend Yield: N/A
• Average Volume (3M): 389.62K
• Price to Earnings (P/E): 57.8
• Beta (1Y): 0.78
• Revenue Growth: 7.41%
• EPS Growth: -22.10%
• Country: US
• Employees: 11,000
• Sector: Healthcare
• Sector Strength: 46
• Industry: Medical - Devices
• EPS (TTM): 1.31
• Shares Outstanding: 34,891,994
• 10 Day Avg. Volume: 439,806
• 30 Day Avg. Volume: 389,624
• PEG Ratio: -1.13
• Price to Book (P/B): 1.60
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 54.45
• Enterprise Value/Market Cap: 0.77
• Enterprise Value/Revenue: 0.47
• Enterprise Value/Gross Profit: 6.97
• Enterprise Value/Ebitda: 2.68
• 1Y Price Target: $147.83
• Price Target Upside: 21.30% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 8

• Rating: 67 Neutral
• Price Target: $131.00 ▲(7.49%Upside)

Integer Holdings' overall score is buoyed by a positive earnings call and strong financial performance, despite a high valuation suggesting overpricing. Technical indicators show neutral trends, contributing moderately to the score.

Positive Factors

Debt Refinancing

Interest expense in 2025 goes down by $13m due to debt refinancing.

Financial Performance

Integer Holdings reported better-than-expected financial results for its 1Q25, including revenues of $437.4 million, up 7.3% year-over-year.

New Product Launches

New product launches should drive significant growth in the C&V sector.

Negative Factors

Sales Performance

CRM & Neuromod sales underperformed expectations, creating a potential area of concern for future growth.

Valuation Metrics

The price target is being lowered to $140 due to reduced valuation metrics for comparable stocks.

Integer Holdings Business Overview & Revenue Model

Company Description

Integer Holdings Corporation (ITGR) is a leading medical device outsource (MDO) manufacturer that serves the medical device industry with innovative, high-quality products and services. The company operates across various sectors, including cardiac and vascular, neuromodulation, orthopedics, advanced surgical, and non-medical markets. Integer provides a broad range of offerings, including components, subassemblies, and complete devices, enabling their clients to bring cutting-edge medical solutions to market efficiently and effectively.

How the Company Makes Money

Integer Holdings generates revenue primarily through the design, development, and manufacturing of medical devices for original equipment manufacturers (OEMs). The company earns money by supplying critical components and fully assembled products in the cardiac, neuromodulation, and vascular segments, among others. Integer's key revenue streams include sales of medical device components like batteries, capacitors, and leads, as well as advanced surgical and orthopedic products. Integer also benefits from strategic partnerships and long-term contracts with major medical device companies, providing a steady and reliable income source. The company's focus on innovation and quality manufacturing processes contributes significantly to its earnings by attracting and retaining a loyal customer base.

Integer Holdings Financial Statement Overview

Summary

Integer Holdings demonstrates strong revenue growth and operational efficiency, supported by solid cash flow generation. However, increased leverage and slightly declining net profit margins suggest the need for careful financial management.

Income Statement

Integer Holdings demonstrates strong revenue growth with a TTM (Trailing-Twelve-Months) increase from the previous year, indicating a healthy growth trajectory. The gross profit margin remains robust, although net profit margins have declined compared to the previous period, suggesting potential efficiency improvements. EBITDA and EBIT margins are solid, reflecting operational strength despite slight fluctuations in net income.

Balance Sheet

The company's balance sheet shows a stable equity ratio, indicating a solid financial foundation with adequate equity backing its assets. The debt-to-equity ratio has increased, suggesting rising leverage which could pose a risk if not managed carefully. Return on equity remains strong, demonstrating effective use of shareholder funds.

Cash Flow

Integer Holdings exhibits consistent operating cash flow, reflecting healthy cash generation from operations. Free cash flow has grown significantly, supporting further investment opportunities. However, the ratio of operating cash flow to net income is slightly lower, implying room for improvement in converting income into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.75B	1.72B	1.60B	1.38B	1.22B	1.07B
Gross Profit	466.21M	459.01M	418.29M	359.01M	336.97M	285.71M
EBITDA	282.39M	310.91M	256.51M	215.40M	215.26M	207.56M
Net Income	76.90M	119.90M	90.65M	66.38M	96.81M	77.26M
Balance Sheet
Total Assets	3.30B	3.08B	2.94B	2.79B	2.58B	2.37B
Cash, Cash Equivalents and Short-Term Investments	31.71M	46.54M	23.67M	24.27M	17.89M	49.21M
Total Debt	1.35B	1.10B	1.05B	1.01B	897.75M	777.55M
Total Liabilities	1.69B	1.46B	1.42B	1.38B	1.23B	1.10B
Stockholders Equity	1.61B	1.62B	1.52B	1.42B	1.35B	1.27B
Cash Flow
Free Cash Flow	111.49M	99.60M	60.27M	41.65M	103.20M	129.90M
Operating Cash Flow	213.24M	205.21M	180.21M	116.38M	156.67M	181.34M
Investing Cash Flow	-224.38M	-195.41M	-163.37M	-200.42M	-271.00M	-56.58M
Financing Cash Flow	1.60M	13.32M	-18.01M	92.48M	81.99M	-88.58M

Integer Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 121.87
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ITGR, the sentiment is Positive. The current price of 121.87 is above the 20-day moving average (MA) of 119.81, above the 50-day MA of 120.10, and below the 200-day MA of 127.90, indicating a neutral trend. The MACD of 0.08 indicates Negative momentum. The RSI at 57.31 is Neutral, neither overbought nor oversold. The STOCH value of 80.18 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ITGR.

Integer Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
INSP	67 Neutral	$3.89B	59.77	10.86%	―	27.11%	―
ITGR	67 Neutral	$4.21B	57.82	4.98%	―	7.41%	-22.10%
LIVN	66 Neutral	$2.50B	30.62	-19.69%	―	7.97%	-592.40%
IRTC	64 Neutral	$4.84B	―	-111.13%	―	20.54%	25.73%
GKOS	58 Neutral	$5.67B	―	-20.36%	―	23.92%	19.82%
PRCT	57 Neutral	$3.22B	―	-27.62%	―	59.36%	19.87%
Sector *	51 Neutral	$7.41B	0.32	-61.11%	2.34%	16.99%	1.69%

Integer Holdings Corporate Events

Integer Holdings Stockholders Approve Key Proposals at Annual Meeting

At the Annual Meeting on May 21, 2025, Integer Holdings‘ stockholders approved several key proposals. These included the election of ten directors for a one-year term, the ratification of Deloitte & Touche LLP as the independent auditors for fiscal year 2025, approval of executive compensation on an advisory basis, and an amendment to the company’s Restated Certificate of Incorporation to include an officer exculpation provision. These decisions are expected to impact the company’s governance and operational strategies moving forward.

The most recent analyst rating on (ITGR) stock is a Buy with a $152.00 price target. To see the full list of analyst forecasts on Integer Holdings stock, see the ITGR Stock Forecast page.

Integer Holdings Announces Leadership Transition Plan

Integer Holdings Corporation announced a leadership transition plan where Joseph Dziedzic will retire as President and CEO on October 24, 2025, with Payman Khales, the current COO, succeeding him. Dziedzic will continue as a Special Advisor until March 31, 2026, to ensure a smooth transition. This change is part of Integer’s strategy to maintain its growth trajectory in high-growth markets by focusing on innovation and operational excellence. The transition is expected to strengthen Integer’s market position and continue its financial objectives of above-market organic sales growth.

Integer Holdings Reports Strong Q1 2025 Performance

Integer Holdings Corporation reported a strong start to 2025, with first-quarter sales increasing by 7% to $437 million and a 14% rise in adjusted operating income. Despite a GAAP loss due to debt conversion expenses, the company saw significant growth in its cardio and vascular segment and adjusted net income. Integer completed a $1.0 billion convertible notes offering, which is expected to reduce interest expenses and support future growth, including acquisitions of Precision Coating and VSi Parylene. The company raised its adjusted EPS outlook, reflecting confidence in continued sales and income growth.

Integer Holdings Minimizes Impact of New Tariffs

On April 11, 2025, Integer Holdings Corporation announced that the recent tariffs are expected to have an immaterial impact on its 2025 financial results, estimating an effect of $1 to $5 million on full-year adjusted operating income. The company has implemented and planned mitigation actions to address these tariffs, which were announced by the U.S. on April 2, 2025. This announcement reflects the company’s strategic positioning to manage external economic challenges and maintain its operational stability.